Skip to main content
. 2018 Aug 24;9(66):32680–32689. doi: 10.18632/oncotarget.26001

Figure 4. Cumulative incidence of grade ≥2 digestive (left panels) or urinary (right panels) toxicity according to CD4 (top panels) and CD8 (bottom panels) RILA.

Figure 4